Skip to content

The effect of reinforced education and guidance with mobile social media app on the opioid titration treatment of cancer-related pain in outpatients

The effect of reinforced education and guidance with mobile social media app on the opioid titration treatment of cancer-related pain in outpatients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021150
Enrollment
Unknown
Registered
2019-01-30
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Regular Group:Timed telephone follow-up
Wechat follow-up group: reinforced education and guidance with Wechat

Sponsors

First Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects voluntarily signed the informed consent for the clinical observation; 2. Digital score of persistent pain (=4) and (or) number of outbreaks of pain (=3 times per day); 3. Pain is mainly caused by physical factors, not mental and psychological factors; 4. Subjects must understand the research process and evaluation, be able to describe symptoms objectively; 5. Subjects or caregivers can use Wechat skillfully.

Exclusion criteria

Exclusion criteria: 1. Subjects had a history of alcohol abuse, drug abuse and/or opium abuse; 2. New antineoplastic drugs or new radiotherapy schemes were used during clinical observation; 3. Cognitive deficits or mental disorders, patients with consciousness disorders; 4. Used opioid analgesia in the past; 5. Any other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Titration time;

Secondary

MeasureTime frame
Compliance;satisfaction;Side effects;Quality of Life;sleep;

Countries

China

Contacts

Public ContactZhiyou Peng

First Affiliated Hospital, School of Medicine, Zhejiang University

464105001@qq.com+86 0571 87235147

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026